Intel’s Healthcare Innovation
Barometer found most people are
optimistic about tech innovations
advancing healthcare and would
use health sensors in their bodies.
The survey was conducted in
December across eight countries
among 12,000 adults.
More than 70% of responders
were receptive to using prescription
bottle sensors or swallowed
monitors to collect ongoing and
actionable personal health data,
the study found.
Intel said the study found 84% of
people would anonymously share
their personal health info if it could
lower medication costs or overall
cost to the system.
Fifty seven per cent of people
believed traditional hospitals would
become obsolete in the future, the
company said.
For more CLICK HERE.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Jan 14
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.